This is a mechanistic review summarizing proposed pathways by which microbiota may influence ICI response, raising questions for future investigation rather than reporting a primary empirical result or clinical trial outcome.
This is a narrative review proposing a theoretical therapeutic strategy combining LZK-PROTAC degradation with dissolving microneedle delivery for OSCC; no clinical trial data, preclinical evidence, or mechanistic validation is presented.
A narrative review of preclinical literature synthesizing nanocarrier design and CRISPR delivery mechanisms, raising research directions rather than reporting original empirical evidence or clinical outcomes.
A narrative review of mechanistic pathways linking protein lactylation to cancer phenotypes; raises questions about therapeutic potential but reports no empirical data, effect sizes, or clinical outcomes.
A literature review summarizing clinical development, technical principles, and experimental results of cell therapy approaches for diabetes, offering a reference for research and clinical translation rather than reporting primary evidence.
This is a narrative review synthesizing mechanistic understanding of how cancer cells exploit UPR signaling; it raises questions about therapeutic opportunity rather than testing efficacy in a clinical or experimental design.
A narrative literature review that raises comparative epidemiological questions about feline mammary tumors across countries without presenting original data, quantitative synthesis, or evidence of systematic methodology.